Showing results (21-30 of 107) with videos related to
Sort By:
Pageof 11
Seminars in Urologic Oncology|November 1, 1996
Immunotherapy and gene therapyB J Gitlitz, A Belldegrun, R A FiglinSeminars in Urology|February 1, 1992
Immunotherapy for renal cell carcinomaA Belldegrun, R Figlin, J Danella, et al.Cellular Immunology|August 25, 1997
Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicityP Frost, C P Ng, A Belldegrun, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluidA Belldegrun, A Kasid, M Uppenkamp, et al.Cancer Surveys|January 1, 1995
Gene therapy: principles and potentialS S Taneja, S Pang, P Cohan, et al.The Urologic Clinics of North America|November 1, 1994
Management of disseminated kidney cancerS S Taneja, W Pierce, R Figlin, et al.The Journal of Urology|June 24, 1999
Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapyJ Naitoh, A Kaplan, F Dorey, et al.Reviews in Urology|September 21, 2006
Nephron-sparing surgery for renal cell carcinomaK H Tsui, A van Ophoven, O Shvarts, et al.Seminars in Oncology|April 18, 2000
Adoptive cellular therapyD M Hoffman, B J Gitlitz, A Belldegrun, et al.Cancer Surveys|January 1, 1995
Surgery from a US perspectiveJ B Dekernion, J R Franklin, A Belldegrun, et al.Pageof 11